Pediatric pneumonia remains one of the leading causes of morbidity and hospitalization among children worldwide, requiring timely diagnosis and comprehensive management to reduce complications and improve outcomes. Pediatric pneumonia encompasses infections of the lower respiratory tract caused by bacteria, viruses, or, less commonly, fungi, with severity ranging from mild, self-limiting illness to life-threatening respiratory distress. Early recognition is critical and involves clinical assessment of symptoms such as cough, fever, tachypnea, chest indrawing, and oxygen saturation, alongside diagnostic investigations like chest radiography and laboratory testing when indicated. Management strategies combine antimicrobial therapy tailored to the causative pathogen, supportive care including oxygen supplementation and hydration, and monitoring for potential complications such as pleural effusion or sepsis. Pediatric pneumonia also emphasizes preventive measures, including routine immunizations, breastfeeding promotion, adequate nutrition, and reduction of exposure to indoor and outdoor air pollutants. Multidisciplinary care involving pediatricians, respiratory therapists, and nursing staff ensures coordinated treatment, patient education, and follow-up to support recovery and prevent recurrent infections. Emerging research in pediatric pneumonia explores novel vaccines, rapid diagnostic tools, and community-based interventions to enhance early detection and accessibility of care. By integrating prompt clinical management, evidence-based preventive strategies, and caregiver education, pediatric pneumonia care aims to reduce morbidity and mortality, improve lung health in children, and strengthen long-term respiratory resilience, highlighting the importance of both acute treatment and ongoing preventive efforts.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation